首页> 外文期刊>Molecular genetics and metabolism >Gene expression profiles of homogentisate-treated Fah-/- Hpd-/-mice using DNA microarrays.
【24h】

Gene expression profiles of homogentisate-treated Fah-/- Hpd-/-mice using DNA microarrays.

机译:使用DNA芯片对经尿黑酸处理的Fah-/-Hpd-/-小鼠的基因表达谱进行分析。

获取原文
获取原文并翻译 | 示例
           

摘要

Hereditary tyrosinemia I (HT I) is a genetic disorder of tyrosine metabolism caused by abnormalities of fumarylacetoacetate hydrolase. Disturbances in tyrosine metabolism lead to increased levels of succinylacetone and succinylacetoacetate. However, the mechanisms causing liver failure, cirrhosis, renal tubular dysfunction, and hepatocarcinoma are still unknown. Alterations in gene expression found in the livers of patients with HT I are responsible for the pathogenesis of this disease, for example acute liver failure. Therefore, gene expression analysis allows us to better understand its pathogenesis. We analyzed gene expressions in tyrosinemia type I model mice with liver failure using microarrays. The results were confirmed by quantitative PCR to evaluate the pathogenesis of tyrosinemia type I. We found that numerous genes, including amino acid metabolism and apoptosis related genes, were up- or down-regulated at the onset of liver failure. These findings are useful in understanding the pathogenesisof hereditary tyrosinemia.
机译:遗传性酪氨酸血症I(HT I)是由富马酰乙酰乙酸水解酶异常引起的酪氨酸代谢遗传疾病。酪氨酸代谢紊乱导致琥珀酰丙酮和琥珀酰乙酰乙酸水平升高。但是,引起肝衰竭,肝硬化,肾小管功能障碍和肝癌的机制仍然未知。 HT I患者肝脏中发现的基因表达改变是该疾病的发病机制,例如急性肝衰竭。因此,基因表达分析使我们能够更好地了解其发病机理。我们使用微阵列分析了肝衰竭的I型酪氨酸血症模型小鼠的基因表达。通过定量PCR评估I型酪氨酸血症的发病机理证实了该结果。我们发现,在肝衰竭发作时,许多基因(包括氨基酸代谢和凋亡相关基因)被上调或下调。这些发现有助于了解遗传性酪氨酸血症的发病机理。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号